Professor of Otolaryngology, Wayne State University
Otolaryngology (ENT)
Dr. George H. Yoo, MD
|
|
Give Review
George works in the field of Otolaryngology (ENT). He went to University of Kansas School of Medicine. He has 4 awards "America's Top Doctors", "America's Top Doctors for Cancer", "Fellow (FACS)" and "Fellow (FAAO-HNS)". George is also a published MD. He has 69 paper published. The most recent paper is: Impact of chromosome 14q loss on survival in primary head and neck squamous cell carcinoma. He accepts Medicare.
Publications
- Cantharidins Induce ER Stress and a Terminal Unfolded Protein Response in OSCC.
- Risk stratification based on thyroid cytology: Can we rely on national data?
- Serum prognostic biomarkers in head and neck Cancer patients.
- TransOral robotic surgery for treatment of obstructive sleep apnea-hypopnea syndrome.
- Drug-induced sleep endoscopy vs awake Müller's maneuver in the diagnosis of severe upper airway obstruction.
- Single-incision transaxillary robotic thyroidectomy: challenges and limitations in a north american population.
- Phase II Study of Gemcitabine and Docetaxel Combination in Patients with Previously Treated Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck.
- Site involvement as a predictor of airway intervention in angioedema.
- XRP6258-induced gene expression patterns in head and neck Cancer carcinoma.
- Intratumoral delivery of docetaxel enhances antitumor activity of Ad-p53 in murine head and neck Cancer xenograft model.
- A phase 2 trial of surgery with perioperative INGN 201 (Ad5CMV-p53) gene therapy followed by chemoradiOtherapy for advanced, resectable squamous cell carcinoma of the ...
- Craniocervical necrotizing fasciitis with and without thoracic extension: management strategies and outcome.
- Effect of docetaxel on the surgical tumor microenvironment of head and neck Cancer in murine models.
- Fine needle aspiration of Head and neck masses in the operating room: accuracy and potential benefits.
- Gefitinib prevents Cancer progression in mice expressing the activated rat HER2/neu.
- Autoantibody approach for serum-based detection of head and neck Cancer.
- Dissecting the Akt/mammalian target of rapamycin signaling network: emerging results from the head and neck Cancer tissue array initiative.
- BMS-275183-induced gene expression patterns in Head and neck carcinoma.
- Breast Cancer expressing the activated HER2/neu is sensitive to gefitinib in vitro and in vivo and acquires resistance through a novel point mutation in the HER2/neu.
- Benefit of postoperative chemoradiotherapy for patients with unknown primary squamous cell carcinoma of the Head and neck.
- Iressa induces cytostasis and augments Fas-Mediated apoptosis in acinic cell adenocarcinoma overexpressing HER2/neu.
- Visual risks of facial fracture repair in the setting of traumatic optic neuropathy.
- Docetaxel associated pathways in cisplatin resistant Head and neck squamous cell carcinoma: a pilot study.
- Pathological distribution of positive lymph nodes in patients with clinically and radiologically N0 oropharyngeal carcinoma: implications for IMRT treatment planning.
- An in vivo evaluation of docetaxel delivered intratumorally in Head and neck squamous cell carcinoma.
- Prognostic significance of G1 cell-cycle inhibitors in early laryngeal Cancer.
- Organ preservation for advanced resectable Cancer of the base of tongue and hypopharynx: a Southwest Oncology Group Trial.
- Enhancement of Ad-p53 therapy with docetaxel in head and neck Cancer.
- Correlation of histopathological variants, cellular DNA content, and clinical outcome in adenoid cystic carcinoma of the salivary Glands.
- Bioactive suture: a novel immunotherapy for head and neck Cancer.
- Microsatellite alterations in african americans with head and neck Cancer.
- Microsatellite analysis of serum DNA in patients with head and neck Cancer.
- Prognostic significance of p53 and FHIT in advanced oropharyngeal carcinoma.
- Sclerosing mucoepidermoid carcinoma with eosinophilia of the thyroid: a case report and review of the literature.
- Docetaxel induced gene expression patterns in Head and neck squamous cell carcinoma using cDNA microarray and PowerBlot.
- In vivo characteristics of HPV-immortalized and carcinogen transformed Oral keratinocytes.
- Predictors of nodal metastasis in salivary gland Cancer.
- A multicenter phase II study of tgDCC-E1A for the intratumoral treatment of patients with recurrent Head and neck squamous cell carcinoma.
- AntiCancer activity of docetaxel in murine salivary gland carcinoma.
- Clinical significance of poor CD3 response in head and neck Cancer.
- The effects of exogenous p53 overexpression on HPV-immortalized and carcinogen transformed Oral keratinocytes.
- Imaging quiz case 4. Dentigerous cyst.
- Imaging quiz case. Noninvasive Aspergillus Sinusitis.
- Functional outcomes of the retromaxillary-infratemporal fossa dissection for advanced Head and neck/skull base lesions.
- Warthin's Tumor: a 40-year experience at The Johns Hopkins Hospital.
- Nasal alar reconstruction: a critical analysis using melolabial island and paramedian foreHead flaps.
- Locally advanced nasopharyngeal Cancer.
- Foreign antigenic peptides delivered to the Tumor as targets of cytotoxic T cells.
- Titanium mesh repair of the severely comminuted frontal sinus fracture.
- Advantages of mandibular reconstruction with the titanium hollow screw osseointegrating reconstruction plate (THORP).
- Prognostic factors in major salivary gland Cancer.
- Gene promoter hypermethylation in tumors and serum of head and neck Cancer patients.
- Lateral oropharyngeal wall and supraglottic airway collapse associated with failure in sleep apnea surgery.
- p53 mutation and locoregional treatment failure in Head and neck squamous cell carcinoma.
- Progression of head and neck Cancer in an in vitro model.
- Craniocervical necrotizing fasciitis: an 11-year experience.
- Phase I trial of intratumoral liposome E1A gene therapy in patients with recurrent breast and head and neck Cancer.
- Neutron radiation enhances cisplatin cytotoxicity independently of apoptosis in human Head and neck carcinoma cells.
- Anti-CD3/anti-CD28 bead stimulation overcomes CD3 unresponsiveness in patients with Head and neck squamous cell carcinoma.
- Assessment of carotid artery invasion in patients with head and neck Cancer.
- Anti-CD3/anti-CD28 monoclonal antibody-coated suture enhances the immune response of patients with Head and neck squamous cell carcinoma.
- Prognostic significance of p53 gene mutations in laryngeal Cancer.
- Impact of chromosome 14q loss on survival in primary Head and neck squamous cell carcinoma.
- Lack of BRCA2 alterations in primary Head and neck squamous cell carcinoma.
- Infrequent inactivation of the retinoblastoma gene despite frequent loss of chromosome 13q in Head and neck squamous cell carcinoma.
- Detection of plasminogen activators in oral Cancer by laser capture microdissection combined with zymography.
- Proteome-wide analysis of Head and neck squamous cell carcinomas using laser-capture microdissection and tandem mass spectrometry.
- TransOral carbon dioxide laser supraglottic laryngectomy and irradiation in stage I, II, and III squamous cell carcinoma of the supraglottic larynx: report of Southwes...
Schools
University of Kansas School of Medicine
Johns Hopkins Bayview M C
Procedures Preformed
- Antrostomy and Antrotomy (Sinus Surgery)
- Diagnostic Nasal and-or Sinus Endoscopy
- Ear Tube Placement
- Excision of Facial Bone
- View All
Conditions Treated
- Acute Laryngitis
- Acute Sinusitis
- Allergic Rhinitis
- Bell's Palsy
- View All
Doctors Specialties
- Ear, Nose, and Throat
- Otolaryngology (ENT)
Accepted Insurances
Awards
- America's Top Doctors
- America's Top Doctors for Cancer
- Fellow (FACS)
- Fellow (FAAO-HNS)
Education
-
Johns Hopkins University -
Johns Hopkins Bayview Medical Center -
University of Kansas School of Medicine
Hospital
-
DMC - Detroit Receiving Hospital -
DMC Harper University Hospital
Drug Facts
| NPI NUMBER | 1396783460 | |
| NPPES Provider LastName | YOO | |
| NPPES Provider FirstName | GEORGE | |
| NPPES Provider ZIPCode | 482012013 | |
| NPPES Provider State | MI | |
| Specialty Description | Otolaryngology | |
| Total Claim Count | 156.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 18.0 | |
| Percent Opioid Claims | 11.54 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1396783460 |
| Last Name Of The Provider | YOO |
| First Name Of The Provider | GEORGE |
| View All |
Similar Doctors
|
Dr. Glendon M. Gardner, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Karen Doyle, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Tamer Ghanem, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph E. Popper, MD |
|
|
Dr. Richard R. Royer, MD |
|
Dr. Francis T. Hall, MD |
|
|
Dr. Daniela M. Burchhardt, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tyson D. Fisher, MD
This Doctor is OpenDoctor Recommended.
|